[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  25.00 0.64% 3,950.00 3,850.00 4,050.00 3,950.00 3,925.00 3,925.00 2,343 09:46:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 10.3 8.2 139.4 28.3 206

Bioventix Share Discussion Threads

Showing 1101 to 1123 of 1350 messages
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
DateSubjectAuthorDiscuss
24/10/2019
11:21
Possibly a Long way to fall then as profits have increased just 1%? Maybe he’s right
toptrump1
24/10/2019
11:20
Oh no, not a "death cross". We're all doomed! @StepOne, as someone who also reduced this year, are you like I am looking at this thinking about buying back in if it gets much lower? At what price if any would you consider a repurchase? Cheers.
spann_703
24/10/2019
11:08
Can you post his analysis from April 2018? See if he predicted share price doubling in 12 months. Thanks, StepOne
stepone68
24/10/2019
10:54
From an expert in chart analysis: BVXP Death cross 23/10/2019 There are longer term H&S/BARF patterns, but the recent development is a bearish flag. This confirms with an eod close below approx 3050. Tp approx 2670 The historical support centred around 3000 really has to hold. There is a potential turn 25/10/2019
toptrump1
22/10/2019
22:53
Finally someone (Biogen) has shown that targetting amyloid clinically with antibodies as a drug successfully treats the Alzheimer's disease. This is very promising for Bioventix colloboration with pre-diagnostics and their diagnostic antibodies to amyloid. It proves amyloid is a valid target to use for monitoring the disease. https://www.bbc.co.uk/news/health-50137041
johnsmith321
22/10/2019
14:05
Hi trident5, ..."ONJohn is giving us plenty to digest...." From his perspective of self-confessed ignorance, too...;-> Truly, we are blessed. ATB
extrader
22/10/2019
13:31
It is an AIM stock - yes. Has your research thrown up any other helpful insights you could share with us? Not to worry if not, as ONJohn is giving us plenty to digest.
trident5
22/10/2019
13:19
This is an AIM stock isn’t it? and as we know when they go down they really go down, shouldn’t worry too much with their impressive track record to date IMHO.
luderitz
22/10/2019
11:27
£10 seems unlikely. Single figures P/E with a yield over 10% and Troponin growth about to start coming through. Can't disagree with the first part of your sentence though :-)
stepone68
22/10/2019
11:21
My charting skills are non-existent, but £10 even possible as in freefall, cant see a recovery for any reason
onjohn
22/10/2019
11:18
down down deeper and down status quo Just sayin 18 quid could be comung
onjohn
22/10/2019
08:21
Ta muchly Boros10. Just from the tone of the medical articles about hs-troponin introduction and the associated protocols I expect them to beat the finnCap estimates. I had not understood that BVXP would be responsible for the pollution diagnostic. I guess/hope production and distribution will be farmed out. apad
apad
22/10/2019
07:33
Freely available (subject to registration) FinnCap report here: Https://researchlibrary.finncap.com/File/View?file=891f2918-0f61-4737-955c-432b2ac13af5
carcosa
22/10/2019
00:17
I'm sorry about earlier. Someone contacted me via twitter and I thought it was you so gave them the call details. I couldn't find your message via ADVFN. The meeting was very positive. Management appear very confident of hitting finnCap's Troponin forecast of £500k in the current year and £1.1m next. They also seem very hopeful on the prospects for the pollution diagnostic. I got the impression they have made very good progress in developing the antibody or antibodies required but their thinking about how to manufacturer the diagnostic and the route to market are less advanced. It would be the first time that Bioventix has created a diagnostic. They believe customers would include research institutions and members of the public. One key positive is that FDA approval would not be required to launch the test.
boros10
21/10/2019
19:56
Any feedback from the Finncap meeting, Leon? apad
apad
21/10/2019
14:39
What is the PE here. Looks a bit high to me.
nobilis
21/10/2019
14:28
Courtesy of bamboo on another thread, I think this has further to fall BVXP, has historical support at 3150, 2990 Chart shows confirmed H&S [3000] and BARF [3200] patterns. Potential turns 21/10 & 7/11/2019 Trades also on NEX:BVXP.GB
toptrump1
21/10/2019
14:15
Smells like Sheep dip
onjohn
21/10/2019
14:11
Leon, Sent you an advfn message, twitter wouldn't let me message you 😊 You're obviously exalted! apad
apad
21/10/2019
10:56
On John, I always listen to the opposite side of every debate as you learn very little new from those who agree with you so I look forward to hearing your arguments. I've no idea how to filter someone. It's not my style.
boros10
21/10/2019
10:48
You'd struggle to classify your comments as 'debate' John.
stepone68
21/10/2019
10:39
:)) filter me if you dont like. was a free country last time i looked,. if you dont like democratic debate then f o to north korea
onjohn
21/10/2019
10:36
Oh dear the Bioventix board discovered by Advfn rampster community. End of sensible debate?"OnJohnFalling on every small saledown 350p by end of day"
boros10
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
ADVFN Advertorial
Your Recent History
LSE
BVXP
Bioventix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210916 15:42:11